Rocket Lab stock drops 8.5% in thin holiday trade — what investors watch next
29 December 2025
2 mins read

Rocket Lab stock drops 8.5% in thin holiday trade — what investors watch next

NEW YORK, December 28, 2025, 6:58 PM ET — Market closed

  • Rocket Lab shares last closed down 8.5% at $70.65 on Friday, pulling back from recent highs. 1
  • The move came in a light-volume, post-Christmas U.S. session with few catalysts and small-cap volatility. 2
  • Attention remains on Rocket Lab’s expanding U.S. defense satellite work after a recent Space Development Agency award. 3

Rocket Lab Corp shares fell 8.5% to close at $70.65 on Friday, a sharp pullback that ended the holiday-shortened week on a weaker note for the high-flying space stock. 1

The drop matters because Rocket Lab’s shares have become a momentum bellwether in the publicly traded space sector, where thin year-end liquidity can amplify moves and prompt profit-taking after big rallies. 4

It also comes as investors weigh whether the company can translate a growing slate of U.S. government work into sustained revenue and margins, a key test as Rocket Lab pushes deeper into defense alongside its launch business. 5

U.S. stocks ended nearly unchanged on Friday in light post-Christmas trading, with few catalysts to drive conviction, Ryan Detrick, chief market strategist at Carson Group, said. “We had a very strong five-day rally, so in a way we’re just simply catching our breath today,” Detrick said. 2

Rocket Lab traded about 23.2 million shares on Friday, up from roughly 16.7 million in the prior session, Nasdaq data showed. 1

Some other space-exposed names also fell in the session, including Virgin Galactic, which dropped 5.4% to close at $3.16, MarketWatch data showed. 6

Rocket Lab has rallied sharply in December, helped by U.S. defense satellite awards that position it against larger, established contractors for pieces of the Pentagon’s proliferated satellite networks. 3

On Dec. 19, the Space Development Agency said it reached agreements with four suppliers — Lockheed Martin, L3Harris Technologies, Northrop Grumman and Rocket Lab — to build 72 satellites worth about $3.5 billion collectively, with 18 satellites each under fixed-price contracts. 3

Rocket Lab said it won an $816 million prime contract — meaning it is the lead contractor responsible for delivery — to design and manufacture 18 satellites for the agency’s Tracking Layer Tranche 3 program. The company said the award includes a $806 million base amount plus up to $10.45 million in options, with additional subsystem opportunities that could lift total value to about $1 billion. 5

A company filing said work would begin immediately and final delivery of the satellites for launch is expected in 2029. 7

Investors have also been tracking Rocket Lab’s broader push beyond its Electron rocket, as it builds out spacecraft and satellite component offerings and develops its next launch vehicle, Neutron. 5

Before the next session, traders will be watching whether Rocket Lab can hold the $70 area, after Friday’s close near that level. A rebound back toward the mid-$70s would put the stock closer to where it ended earlier in the week. 1

On the macro side, investors are heading into the final few sessions of 2025 with an eye on year-end portfolio adjustments, which Reuters reported could add volatility when light trading volumes can exaggerate price moves. Reuters also flagged minutes from the Federal Reserve’s most recent meeting, due on Tuesday next week, as a key calendar item for rate expectations. 4

Rocket Lab has not confirmed its next earnings publication date, but Zacks expects the company’s next report around Feb. 26, 2026, which investors will treat as a likely near-term catalyst for updated guidance and contract execution details. 8

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
New York, Feb 7, 2026, 09:35 EST — Market closed. Roivant Sciences Ltd shares leapt on Friday after the company reported positive mid-stage results for its immune-modulating drug brepocitinib in a rare skin disease, and paired the readout with its quarterly financial update. The Nasdaq-listed stock closed up 22.4% at $25.82, leaving traders to gauge whether the move has legs when U.S. markets reopen on Monday, Feb. 9. It matters because Roivant is trying to turn a late-stage pipeline into approvals, and the market has been quick to reward biotechs that can show clean efficacy in controlled trials. The company
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
A massive asteroid will skim past Earth in 2029 — and a Swiss-built camera is gearing up to watch it
Previous Story

A massive asteroid will skim past Earth in 2029 — and a Swiss-built camera is gearing up to watch it

Silver breaks $80 as Musk warns manufacturers face fallout from soaring metal prices
Next Story

Silver breaks $80 as Musk warns manufacturers face fallout from soaring metal prices

Go toTop